Summary of clinical experience with recombinant factor VIII products — Kogenate

Publisher Website

1 May 1994

journal article
clinical trial
Published by Springer Nature in Annals of Hematology

Vol. 68 (S3), S3-S6
https://doi.org/10.1007/bf01774521

Abstract

No abstract available

This publication has 4 references indexed in Scilit:

Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII
The Lancet, 1993
Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of Inhibitors
New England Journal of Medicine, 1993
Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs
The Lancet, 1992
Human Recombinant DNA–Derived Antihemophilic Factor (Factor VIII) in the Treatment of Hemophilia A
New England Journal of Medicine, 1990

Cited by 13 articles